Actively Recruiting
Nebulized Bupivacaine Analgesia for Cleft Palate Repair
Led by Assiut University · Updated on 2026-01-02
60
Participants Needed
1
Research Sites
274 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study we introduce a potent local anesthetic; bupivacaine 0.5% in 0.5 mg/kg dose by nebulization as a preemptive analgesia to compare efficacy and safety in children with cleft palate repair.
CONDITIONS
Official Title
Nebulized Bupivacaine Analgesia for Cleft Palate Repair
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 1 to 7 years
- American Society of Anaesthesiologists physical status (ASA) I-II
- Scheduled for elective cleft palate repair with or without cleft lip surgery under general anesthesia
You will not qualify if you...
- Coronary artery disease
- Hypertension
- Developmental delay
- Allergy to study drug
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Assiut university hospital
Asyut, Assuit, Egypt, Assuit universi
Actively Recruiting
Research Team
O
Omar Soliman, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here